Trial Profile
Phase I/II trial of chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced esophageal cancer
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Feb 2020
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Feb 2015 New trial record